Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ) SHZ

9.62

+0.21(+2.23%)

Updated at October 31 11:46AM

Currency In CNY

Valuation

Market Cap3.69B
Enterprise Value3.11B
P/E Ratio-29.27
PEG Ratio2.12
Price/Sales Ratio2.38
Price/Book Ratio2.44
Enterprise/Revenue2.06
Enterprise/EBITDA-32.75

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.08
Operating Margin-0.05

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.08

Income Statement

Revenue1.74B
Revenue/Share4.05
Gross Profit384.72M
EBITDA-14.04M
Net Income-109.44M
Diluted EPS-0.27

Balance Sheet

Total Cash707.63M
Total Cash/Share1.78
Total Debt196.76M
Total Debt/Equity0.13
Current Ratio2.81
Book Value Per Share4.16

Price History

52-Week Change-6.24
52-Week High12.66
52-Week Low7.66
Moving Average 50 Days9.59
Moving Average 200 Days9.81

Statistics

Average Volume5.6M
Shares Outstanding398.55M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield2.08
Payout Ratio-0.69
Last Split FactorN/A
Last Split DateN/A